In vitro activity of ceftolozane/tazobactam against Gram‐negative isolates collected from ICU patients with lower respiratory tract infections in seven Asian countries

In vitro activity of ceftolozane/tazobactam against Gram‐negative isolates collected from ICU patients with lower respiratory tract infections in seven Asian countries—SMART 2017–2019

Published:2021-12 Issue: Volume: Page:
ISSN:2213-7165
Container-title:Journal of Global Antimicrobial Resistance
language:en
Short-container-title:Journal of Global Antimicrobial Resistance

Author:

Lob Sibylle H.,Kazmierczak Krystyna M.,Chen Wei-Ting,Siddiqui Fakhar,DeRyke C. Andrew^ORCID,Young Katherine,Motyl Mary R.^ORCID,Sahm Daniel F.

Funder

Merck & Co Inc

Publisher

Elsevier BV

Subject

Microbiology (medical),Immunology,Immunology and Allergy,Microbiology

Reference33 articles.

1. Antimicrobial resistance,2020

2. ZERBAXA (ceftolozane/tazobactam) for injection, for intravenous use. Package insert,2020

3. Activity of ertapenem against Enterobacteriaceae in seven global regions—SMART 2012–2016;Lob;Eur J Clin Microbiol Infect Dis,2018

4. Antimicrobial Susceptibility Among Gram-Negative Isolates Collected From Intensive Care Units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle East, and Africa Between 2004 and 2009 as Part of the Tigecycline Evaluation and Surveillance Trial

5. Carbapenem-resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia;Hsu;Clin Microbiol Rev,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro activity of ceftolozane/tazobactam against Gram-negative bacilli isolated from pediatric patients: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) 2017–2021, China;Journal of Global Antimicrobial Resistance;2024-09

2. Ceftolozane/tazobactam: Literature review of its activity on Taiwanese isolates before its launch in Taiwan (2012–2021);Heliyon;2024-07

3. Temporal and geographical prevalence of carbapenem-resistant Pseudomonas aeruginosa and the in vitro activity of ceftolozane/tazobactam and comparators in Taiwan—SMART 2012–2021;Journal of Global Antimicrobial Resistance;2023-09

4. Antimicrobial Susceptibility and Molecular Features of Colonizing Isolates of Pseudomonas aeruginosa and the Report of a Novel Sequence Type (ST) 3910 from Thailand;Antibiotics;2023-01-12

5. In Vitro Activity of Ceftolozane-Tazobactam and Other Antibiotics against Pseudomonas aeruginosa Infection-Isolates from an Academic Medical Center in Thailand;Antibiotics;2022-05-30